Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease
EQUALISER
The Russian Multicenter Observational Program Obtaining of Data on the Impact of Different Treatment Modalities on the Quality of Life of the Patients With Acute and Chronic Hemorrhoid Disease
1 other identifier
observational
1,032
1 country
1
Brief Summary
The program is aimed at obtaining data on the impact of the method and type of treatment on the quality of life of patients with acute or chronic hemorrhoids with option of conservative treatment with Detralex
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2018
CompletedFirst Posted
Study publicly available on registry
November 16, 2018
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2019
CompletedResults Posted
Study results publicly available
March 29, 2021
CompletedMarch 29, 2021
March 1, 2021
3 months
November 13, 2018
December 4, 2020
March 23, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)
The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
1 month after presenting to a doctor
Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients
QoL assessment using the SF36 scale questioner ( assessment of QoL quastions) - added to the Referance The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
1 month after presenting to a doctor
Study Arms (3)
Surgical treatment of Hemmorhoid
Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.)
Conservative treatment of Hemmorhoid
Patients taken conservative treatment (Detralex)
Combined treatment of Hemmorhoid
Combined treatment patients (surgery and conservative treatment)
Interventions
Surgical procedures for treatment of Hemorhoid
Eligibility Criteria
Patients with acute or chronic hemorrhoids.
You may qualify if:
- Age over 18 years;
- Absence of conditions requiring urgent medical care and not related to hemorrhoids;
- The patient was diagnosed with:
- Acute hemorrhoids;
- Exacerbation of chronic hemorrhoids;
- Chronic hemorrhoids
You may not qualify if:
- The patient is consulting for an urgent issue not related to hemorrhoids;
- The presence of severe systemic diseases;
- Pregnancy;
- Inability to understand the meaning of the Program and follow the doctor's recommendations
- Patients with inflammatory bowel diseases
- Patients with concomitant diseases of the anal canal
- Patients taking anticoagulants;
- Patients with previous anorectal surgeries, including hemorrhoidectomy or excision of anal fistula.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Servier Russialead
Study Sites (1)
Pirogov National Surgery Center
Moscow, Pervomaisrfya 70, 105203, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Olga Linnik
- Organization
- AO Servier
Study Officials
- STUDY CHAIR
Olga LINNIK
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2018
First Posted
November 16, 2018
Study Start
March 1, 2019
Primary Completion
June 5, 2019
Study Completion
June 5, 2019
Last Updated
March 29, 2021
Results First Posted
March 29, 2021
Record last verified: 2021-03